Salam Al-karadaghi
Fondateur chez SARomics Biostructures AB
Provenance du réseau au premier degré de Salam Al-karadaghi
Entité | Type d'entité | Industrie | |
---|---|---|---|
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden.
8
| Holding Company | Biotechnology | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Salam Al-karadaghi via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
University of Lund | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
Faculty of Engineering, Lund University | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Sound Bioventures Management AB
Sound Bioventures Management AB Investment ManagersFinance Sound Bioventures Management AB is a venture capital firm founded in 2021 by Casper Breum, Johan Kordel and Bibhash Mukhopadhyay. The firm is headquartered in Malmo, Sweden. | Investment Managers | Founder | |
Ziarco Pharma Ltd.
Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Director/Board Member | |
BONE SUPPORT AB
BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member | |
ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Sound Biotech ApS | Chief Executive Officer | ||
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
RENEO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Curzion Pharmaceuticals, Inc.
Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Consultant / Advisor | |
AAK AB | Food: Specialty/Candy | Corporate Officer/Principal | |
BONESUPPORT HOLDING AB | Medical Specialties | Director/Board Member | |
LU Holding AB
LU Holding AB Investment ManagersFinance LU Holding AB (LU Holding) is a venture capital subsidiary of University of Lund founded in 1994. The firm is headquartered in Lund, Sweden. | Investment Managers | Private Equity Analyst | |
SAGA Diagnostics AB
SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Medical/Nursing Services | Chairman | |
Akuru Pharma AB
Akuru Pharma AB BiotechnologyHealth Technology Akuru Pharma AB engages in the development of research and technology. It focuses on exploiting the abnormal expression of transporter proteins in kidney cancer for developing novel diagnostic and treatment modalities. The company was founded by Jennifer Hansson, Hakan Axelson, and Johanna Asklin on April 14, 2016 and is headquareterd in Lund, Sweden. | Biotechnology | Director/Board Member | |
ARCEDE PHARMA AB | Miscellaneous Commercial Services | Director/Board Member | |
University of Gothenburg | College/University | Doctorate Degree | |
CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Chief Executive Officer | |
ACUCORT AB | Pharmaceuticals: Major | Chairman | |
STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Chairman | |
Monsanto Crop Sciences Sweden AB | Sales & Marketing | ||
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Sales & Marketing | |
Medinvest AB | Private Equity Investor | ||
Flood Vision, Inc. | Director/Board Member | ||
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Radiometer A/S
Radiometer A/S Medical SpecialtiesHealth Technology Radiometer A/S develops as well as manufactures blood gas instruments and support devices. It supplies blood gas analyzers that measure blood gases and other parameters used to diagnose critically ill patients. It also provides accessories, IT systems and support services for blood gas testing, besides producing instruments that measure blood gases transcutaneously. The company consists of three subsidiaries Radiometer Medical ApS (Denmark), SenDx Medical, Inc. (US) and Radiometer Basel AG (Switzerland). Radiometer was founded in 1935 and is headquartered in Br?nsh?j, Denmark. | Medical Specialties | Sales & Marketing | |
SOLIDX AB | Miscellaneous Commercial Services | Director/Board Member | |
Knobe Strat&Med AB | Director/Board Member | ||
Fastighets AB Swenson & Co. | Director/Board Member | ||
Extreme Engineering Ltd.
Extreme Engineering Ltd. Oilfield Services/EquipmentIndustrial Services Extreme Engineering Ltd. develops and manufactures custom and drilling telemetry systems. It focuses on developing, engineering and manufacturing a new suite of MWD tools – Mud Pulse and Electromagnetic. The firm also supports their massive drilling fleet, and an inventive engineering team they could utilize for “Quick to Market” development of game changing technologies. The company was founded by Derek W. Logan in 2001 and and is headquartered in Calgary, Canada. | Oilfield Services/Equipment | Chief Executive Officer | |
University of Glasgow | College/University | Undergraduate Degree | |
University of Oxford | College/University | Doctorate Degree | |
Hifi Engineering, Inc.
Hifi Engineering, Inc. Packaged SoftwareTechnology Services Hifi Engineering, Inc. specializes in Fiber Optic Monitoring. It develops turnkey distributed fiber optic sensing systems sensors, hardware and visualization software focused on downhole and pipe applications. The company was founded by John Hull in 2007 and is headquartered in Calgary, Australia. | Packaged Software | Corporate Officer/Principal | |
FLERIE INVEST AB | Pharmaceuticals: Major | Director/Board Member | |
River Vision Development Corp.
River Vision Development Corp. BiotechnologyHealth Technology River Vision Development Corp. develops novel protein therapies. The firm provides therapy for the treatment of graves orbitopathy which is a condition in which an autoimmune response is mounted against tissues behind the eye, causing inflammation, tissue proliferation and excess production of extracellular matrix. The company was founded in 2011 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
EQL PHARMA AB | Pharmaceuticals: Generic | Director/Board Member | |
KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Chori Pars AB | Chief Executive Officer | ||
Respiratorius AB
Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
iNovacia AB
iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Miscellaneous Commercial Services | Founder | |
Ipsen Bioinnovation Ltd.
Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Lundbeckfonden Ventures
Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Investment Managers | Consultant / Advisor | |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Suède | 31 |
Royaume-Uni | 8 |
Etats-Unis | 8 |
Danemark | 4 |
Canada | 3 |
Sectorielle
Health Technology | 26 |
Consumer Services | 6 |
Commercial Services | 6 |
Finance | 5 |
Consumer Non-Durables | 2 |
Opérationnelle
Director/Board Member | 34 |
Founder | 9 |
Corporate Officer/Principal | 8 |
Doctorate Degree | 6 |
Graduate Degree | 6 |
Relations les plus connectées
- Bourse
- Insiders
- Salam Al-karadaghi
- Connexions Sociétés